Table 2.
Paired analysis of tumor cells before and after NACT
| Tumor cells after NACT | |||
|---|---|---|---|
| Tumor cells before NACT | Negative | Positive | Total |
| Total | 96 | 22 (19 %) | 118 |
| DTC-negative | 73 | 14 | 87 |
| DTC-positive | 23 | 8 | 31 (26 %) |
| Total | 82 | 10 (11 %) | 92 |
| CTC-negative | 58 | 9 | 67 |
| CTC-positive | 24 | 1 | 25 (27 %) |
| Total | 39 | 9 (19 %) | 48 |
| slCTC-negative | 18 | 1 | 19 |
| slCTc-positive | 21 | 8 | 29 (60 %) |
CTC circulating tumor cell, DTC disseminated tumor cell, NACT neoadjuvant chemotherapy